1-5 of 5
Christof Scheid
Close
Sort by
Journal Articles

PTCy versus CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin Lymphoma: a study of the LWP of the EBMT

Juan Montoro, Maud Ngoya, Alexander Kulagin, Sebastian Giebel, Annoek E.C. Broers, Stefania Bramanti, Khalid Halahleh, Jose Antonio Perez-Simon, Carlos Solano, Tulay Ozcelik, Didier Blaise, Jaime Sanz, Marta Henriques, Régis Peffault de Latour, Rodrigo Martino, Christof Scheid, Laura Fox, Tomasz Gromek, Manuel Jurado, Ioanna Sakellari, Gwendolyn van Gorkom, Paola Matteucci, Arnon Nagler, Yener Koc, Bertram Glass
Journal: Blood Advances
Blood Adv bloodadvances.2024013328.
https://doi.org/10.1182/bloodadvances.2024013328
Published: 2024
Journal Articles

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Matthew Collin, Jakob Passweg, Claude E. Bulabois, Anjum Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G. Kulasekararaj, Patrick J. Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsène Mekinian, Sinisa Savic, Maria Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Tobias Alexander, Marie Robin, Raffaella Greco, Donal P. McLornan
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1444–1448.
https://doi.org/10.1182/bloodadvances.2023012478
Published: 2024
Includes: Supplemental data
Journal Articles

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Clinical Trials & Observations
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann
Journal: Blood Advances
Blood Adv (2022) 6 (2): 515–520.
https://doi.org/10.1182/bloodadvances.2021005532
Published: 2022
Includes: Supplemental data
Journal Articles

Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD

Clinical Trials & Observations
Madan Jagasia, Christof Scheid, Gérard Socié, Francis Ayuketang Ayuk, Johanna Tischer, Michele L. Donato, Árpád Bátai, Heidi Chen, Sheau-Chiann Chen, Thomas Chin, Henri Boodée, Ghaith Mitri, Hildegard T. Greinix
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2218–2229.
https://doi.org/10.1182/bloodadvances.2019000145
Published: 2019
Includes: Supplemental data
Journal Articles

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Maximilian Merz, Anna Jauch, Thomas Hielscher, Tilmann Bochtler, Stefan Olaf Schönland, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc Steffen Raab, Jens Hillengass, Hans Salwender, Igor Wolfgang Blau, Hans-Walter Lindemann, Ingo G. H. Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood Advances
Blood Adv (2017) 2 (1): 1–9.
https://doi.org/10.1182/bloodadvances.2017013334
Published: 2017
Includes: Supplemental data